Latest filing published 22 Jun 2020 for Integra Lifesciences Holdings CORP, €25.9M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Richard E. Caruso: trading record in brief
Richard E. Caruso is a declared insider at 2 companies; the most frequent names are Integra Lifesciences Holdings Corp and SeaSpine Holdings Corp. In total, 44 filings cover trades dated from 27 April 2006 to 18 June 2020.
On the open market, the record shows 1 purchase worth €42k and 18 sales worth €110.7M. The net balance comes to €110.7M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 11 share grants and 13 option exercises. In 2020 alone, the filings show no purchases and 2 sales.
The record was last updated on 22 June 2020 with an open-market sale (€25.9M) in Integra Lifesciences Holdings Corp. The clock since the last published purchase (21 November 2011) now reads 5,467 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard E. Caruso
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 600,000 shares@ US$48.4749.3% of flowCommon StockSEC:0001209191-20-038142:0
- 4,921 shares@ US$9.4347.2% of flowCommon StockSEC:0001615594-20-000026:0
- 4,921 shares@ US$10.5652.8% of flowCommon StockSEC:0001615594-20-000026:1
- 15,658 shares@ US$14.650.4% of flowCommon StockSEC:0001209191-20-025600:0
- 13,876 shares@ US$14.650.4% of flowCommon StockSEC:0001209191-20-025600:1
- 491,205 shares@ US$59.4229.0% of flowCommon StockSEC:0001209191-19-061524:0
- 520,000 shares@ US$60.9731.7% of flowCommon StockSEC:0001209191-19-050354:0
- 80,000 shares@ US$61.774.9% of flowCommon StockSEC:0001209191-19-047398:0
- 5,020 shares@ US$15.1730.6% of flowCommon StockSEC:0001637761-19-000065:1
- 5,020 shares@ US$14.1528.6% of flowCommon StockSEC:0001637761-19-000065:0
- 9,250 shares@ US$21.970.2% of flowCommon StockSEC:0001209191-19-019753:0
- 9,250 shares@ US$56.060.5% of flowCommon StockSEC:0001209191-19-019753:1
- 20,878 shares@ US$21.970.4% of flowCommon StockSEC:0001209191-19-019753:2
- 20,878 shares@ US$56.061.1% of flowCommon StockSEC:0001209191-19-019753:3
- 23,338 shares@ US$63.221.4% of flowCommon StockSEC:0001209191-18-055574:0
- 23,338 shares@ US$63.161.4% of flowCommon StockSEC:0001209191-18-055574:1
- 12,002 shares@ US$18.060.2% of flowCommon StockSEC:0001209191-18-018856:0
- 12,002 shares@ US$53.680.6% of flowCommon StockSEC:0001209191-18-018856:1
- 20,878 shares@ US$18.060.3% of flowCommon StockSEC:0001209191-18-018856:2
- 20,878 shares@ US$53.681.0% of flowCommon StockSEC:0001209191-18-018856:3
- 2,341 shares0Common StockSEC:0001209191-16-123615:0
- 15,699 sharesCommon StockSEC:0001209191-16-097541:0
- 2,296 shares0Common StockSEC:0001209191-15-047194:0
- 2,822 shares0Common StockSEC:0001209191-14-036151:0
- 2,055 shares0Common StockSEC:0001209191-13-028811:0
25 of 44 declarations
